Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the End-Stage Kidney Disease Treatment industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
BLR Bio LLC
Novartis AG
F Hoffmann-La Roche Ltd
CTI BioPharma Corp
Prolong Pharmaceuticals LLC
By Type:
Others
Tesidolumab
Pacritinib
Sanguinate
MK-3866
By Application:
Clinic
Others
Hospital
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China End-Stage Kidney Disease Treatment Market Overview 2018-2029
-
1.1 China End-Stage Kidney Disease Treatment Industry Development Overview
-
1.2 China End-Stage Kidney Disease Treatment Industry Development History
-
1.3 China End-Stage Kidney Disease Treatment Industry Market Size (2018-2029)
-
1.4 China End-Stage Kidney Disease Treatment Market Analysis by Type from Production Side
-
1.4.1 China End-Stage Kidney Disease Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.2 China End-Stage Kidney Disease Treatment Production Volume, Production Value and Growth Rate of Tesidolumab (2018-2029)
-
1.4.3 China End-Stage Kidney Disease Treatment Production Volume, Production Value and Growth Rate of Pacritinib (2018-2029)
-
1.4.4 China End-Stage Kidney Disease Treatment Production Volume, Production Value and Growth Rate of Sanguinate (2018-2029)
-
1.4.5 China End-Stage Kidney Disease Treatment Production Volume, Production Value and Growth Rate of MK-3866 (2018-2029)
-
1.5 China End-Stage Kidney Disease Treatment Market Analysis by Application from Consumption End
-
1.5.1 China End-Stage Kidney Disease Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.2 China End-Stage Kidney Disease Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China End-Stage Kidney Disease Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.6 China End-Stage Kidney Disease Treatment Market Analysis by Region
-
1.6.1 North China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
1.6.3 South China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
1.6.4 East China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
Chapter 2 China End-Stage Kidney Disease Treatment Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on End-Stage Kidney Disease Treatment Market Status and Competition at home and abroad in 2023
-
2.2.2 China End-Stage Kidney Disease Treatment Market Status and Competition Analysis in 2023
-
2.2.3 China End-Stage Kidney Disease Treatment Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China End-Stage Kidney Disease Treatment Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on End-Stage Kidney Disease Treatment Industry Development
Chapter 3 End-Stage Kidney Disease TreatmentIndustry Chain Analysis
-
3.1 End-Stage Kidney Disease Treatment Industry Chain
-
3.2 End-Stage Kidney Disease Treatment Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the End-Stage Kidney Disease Treatment Market
-
3.3 End-Stage Kidney Disease Treatment Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the End-Stage Kidney Disease Treatment Market
Chapter 4 China End-Stage Kidney Disease Treatment Market, by Type
-
4.1 China End-Stage Kidney Disease Treatment Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China End-Stage Kidney Disease Treatment Total Production Volume and Growth Rate from Production Side
-
4.5 China End-Stage Kidney Disease Treatment Production Volume and Growth Rate, by Type
-
4.5.1 China End-Stage Kidney Disease Treatment Production Volume and Growth Rate of Others
-
4.5.2 China End-Stage Kidney Disease Treatment Production Volume and Growth Rate of Tesidolumab
-
4.5.3 China End-Stage Kidney Disease Treatment Production Volume and Growth Rate of Pacritinib
-
4.5.4 China End-Stage Kidney Disease Treatment Production Volume and Growth Rate of Sanguinate
-
4.5.5 China End-Stage Kidney Disease Treatment Production Volume and Growth Rate of MK-3866
Chapter 5 China End-Stage Kidney Disease Treatment Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China End-Stage Kidney Disease Treatment Total Market Size and Growth Rate from Consumption End
-
5.5 China End-Stage Kidney Disease Treatment Market Size and Growth Rate, by Application
-
5.5.1 China End-Stage Kidney Disease Treatment Market Size and Growth Rate of Clinic
-
5.5.2 China End-Stage Kidney Disease Treatment Market Size and Growth Rate of Others
-
5.5.3 China End-Stage Kidney Disease Treatment Market Size and Growth Rate of Hospital
Chapter 6 China End-Stage Kidney Disease Treatment Market, by Region
-
6.1 China End-Stage Kidney Disease Treatment Production Volume and Production Value, by Region
-
6.2 China End-Stage Kidney Disease Treatment Sales Volume and Sales Value, by Region
Chapter 7 North China End-Stage Kidney Disease Treatment Market Analysis
-
7.1 North China End-Stage Kidney Disease Treatment Market, by Type
-
7.2 North China End-Stage Kidney Disease Treatment Market, by Application
Chapter 8 Central China End-Stage Kidney Disease Treatment Market Analysis
-
8.1 Central China End-Stage Kidney Disease Treatment Market, by Type
-
8.2 Central China End-Stage Kidney Disease Treatment Market, by Application
Chapter 9 South China End-Stage Kidney Disease Treatment Market Analysis
-
9.1 South China End-Stage Kidney Disease Treatment Market, by Type
-
9.2 South China End-Stage Kidney Disease Treatment Market, by Application
Chapter 10 East China End-Stage Kidney Disease Treatment Market Analysis
-
10.1 East China End-Stage Kidney Disease Treatment Market, by Type
-
10.2 East China End-Stage Kidney Disease Treatment Market, by Application
Chapter 11 Northeast China End-Stage Kidney Disease Treatment Market Analysis
-
11.1 Northeast China End-Stage Kidney Disease Treatment Market, by Type
-
11.2 Northeast China End-Stage Kidney Disease Treatment Market, by Application
Chapter 12 Southwest China End-Stage Kidney Disease Treatment Market Analysis
-
12.1 Southwest China End-Stage Kidney Disease Treatment Market, by Type
-
12.2 Southwest China End-Stage Kidney Disease Treatment Market, by Application
Chapter 13 Northwest China End-Stage Kidney Disease Treatment Market Analysis
-
13.1 Northwest China End-Stage Kidney Disease Treatment Market, by Type
-
13.2 Northwest China End-Stage Kidney Disease Treatment Market, by Application
Chapter 14 Company Profiles
-
14.1 BLR Bio LLC
-
14.1.1 BLR Bio LLC Company Profile
-
14.1.2 BLR Bio LLC End-Stage Kidney Disease Treatment Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Novartis AG
-
14.2.1 Novartis AG Company Profile
-
14.2.2 Novartis AG End-Stage Kidney Disease Treatment Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 F Hoffmann-La Roche Ltd
-
14.3.1 F Hoffmann-La Roche Ltd Company Profile
-
14.3.2 F Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 CTI BioPharma Corp
-
14.4.1 CTI BioPharma Corp Company Profile
-
14.4.2 CTI BioPharma Corp End-Stage Kidney Disease Treatment Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Prolong Pharmaceuticals LLC
-
14.5.1 Prolong Pharmaceuticals LLC Company Profile
-
14.5.2 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Market Performance
-
14.5.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 End-Stage Kidney Disease Treatment Industry Research Conclusions
-
15.2 End-Stage Kidney Disease Treatment Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China End-Stage Kidney Disease Treatment Industry Market Size (2018-2029)
-
Figure China End-Stage Kidney Disease Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China End-Stage Kidney Disease Treatment Production Volume, Production Value and Growth Rate of Tesidolumab (2018-2029)
-
Figure China End-Stage Kidney Disease Treatment Production Volume, Production Value and Growth Rate of Pacritinib (2018-2029)
-
Figure China End-Stage Kidney Disease Treatment Production Volume, Production Value and Growth Rate of Sanguinate (2018-2029)
-
Figure China End-Stage Kidney Disease Treatment Production Volume, Production Value and Growth Rate of MK-3866 (2018-2029)
-
Figure China End-Stage Kidney Disease Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China End-Stage Kidney Disease Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China End-Stage Kidney Disease Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure North China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
Figure Central China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
Figure South China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
Figure East China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northeast China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
Figure Southwest China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northwest China End-Stage Kidney Disease Treatment Market Size and Growth Rate from 2018-2029
-
Figure End-Stage Kidney Disease Treatment Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China End-Stage Kidney Disease Treatment Market Share by Type in 2018
-
Figure China End-Stage Kidney Disease Treatment Market Share by Type in 2023
-
Figure China End-Stage Kidney Disease Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Production Volume and Growth Rate of Others (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Production Volume and Growth Rate of Tesidolumab (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Production Volume and Growth Rate of Pacritinib (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Production Volume and Growth Rate of Sanguinate (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Production Volume and Growth Rate of MK-3866 (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Market Share by Application in 2018
-
Figure China End-Stage Kidney Disease Treatment Market Share by Application in 2023
-
Figure China End-Stage Kidney Disease Treatment Total Market Size and Growth Rate from Consumption End
-
Figure China End-Stage Kidney Disease Treatment Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Market Size and Growth Rate of Others (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Market Size and Growth Rate of Hospital (2018-2023)
-
Table China End-Stage Kidney Disease Treatment Production Volume by Region (2018-2023)
-
Table China End-Stage Kidney Disease Treatment Production Volume Share by Region (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Production Volume Share by Region (2018-2023)
-
Table China End-Stage Kidney Disease Treatment Production Value by Region (2018-2023)
-
Table China End-Stage Kidney Disease Treatment Production Value Share by Region (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Production Value Share by Region (2018-2023)
-
Table China End-Stage Kidney Disease Treatment Sales Volume by Region (2018-2023)
-
Table China End-Stage Kidney Disease Treatment Sales Volume Share by Region (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Sales Volume Share by Region (2018-2023)
-
Table China End-Stage Kidney Disease Treatment Sales Value by Region (2018-2023)
-
Table China End-Stage Kidney Disease Treatment Sales Value Share by Region (2018-2023)
-
Figure China End-Stage Kidney Disease Treatment Sales Value Share by Region (2018-2023)
-
Table North China End-Stage Kidney Disease Treatment Production Volume by Type (2018-2023)
-
Table North China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Figure North China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Table North China End-Stage Kidney Disease Treatment Sales Volume by Application (2018-2023)
-
Table North China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Figure North China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Table Central China End-Stage Kidney Disease Treatment Production Volume by Type (2018-2023)
-
Table Central China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Figure Central China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Table Central China End-Stage Kidney Disease Treatment Sales Volume by Application (2018-2023)
-
Table Central China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Figure Central China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Table South China End-Stage Kidney Disease Treatment Production Volume by Type (2018-2023)
-
Table South China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Figure South China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Table South China End-Stage Kidney Disease Treatment Sales Volume by Application (2018-2023)
-
Table South China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Figure South China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Table East China End-Stage Kidney Disease Treatment Production Volume by Type (2018-2023)
-
Table East China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Figure East China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Table East China End-Stage Kidney Disease Treatment Sales Volume by Application (2018-2023)
-
Table East China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Figure East China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Table Northeast China End-Stage Kidney Disease Treatment Production Volume by Type (2018-2023)
-
Table Northeast China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Figure Northeast China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Table Northeast China End-Stage Kidney Disease Treatment Sales Volume by Application (2018-2023)
-
Table Northeast China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northeast China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Table Southwest China End-Stage Kidney Disease Treatment Production Volume by Type (2018-2023)
-
Table Southwest China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Figure Southwest China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Table Southwest China End-Stage Kidney Disease Treatment Sales Volume by Application (2018-2023)
-
Table Southwest China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Figure Southwest China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Table Northwest China End-Stage Kidney Disease Treatment Production Volume by Type (2018-2023)
-
Table Northwest China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Figure Northwest China End-Stage Kidney Disease Treatment Production Volume Share by Type (2018-2023)
-
Table Northwest China End-Stage Kidney Disease Treatment Sales Volume by Application (2018-2023)
-
Table Northwest China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northwest China End-Stage Kidney Disease Treatment Sales Volume Share by Application (2018-2023)
-
Table BLR Bio LLC Company Profile
-
Table BLR Bio LLC End-Stage Kidney Disease Treatment Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG End-Stage Kidney Disease Treatment Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue, Price and Gross (2018-2023)
-
Table CTI BioPharma Corp Company Profile
-
Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue, Price and Gross (2018-2023)
-
Table Prolong Pharmaceuticals LLC Company Profile
-
Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue, Price and Gross (2018-2023)
-
